Evidence map›Paper›PMID 36614187›Full record

ArticleInternational journal of molecular sciences2023

Anammox Bacterial

Tesshin Uegaki, Taisei Takei, Shuhei Yamaguchi, Keisuke Fujiyama, Yusuke Sato, Tomoya Hino, Shingo Nagano

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tesshin UegakiDepartment of Chemistry, Graduate School of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.ORCID 0000-0002-3401-7770
Taisei TakeiDepartment of Chemistry and Biotechnology, Faculty of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.
Shuhei YamaguchiDepartment of Engineering, Graduate School of Sustainability Science, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.
Keisuke FujiyamaDepartment of Chemistry, Graduate School of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.ORCID 0000-0003-0960-353X
Yusuke SatoDepartment of Chemistry, Graduate School of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.ORCID 0000-0001-8495-8950
Tomoya HinoDepartment of Chemistry, Graduate School of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.ORCID 0000-0002-8813-4622
Shingo NaganoDepartment of Chemistry, Graduate School of Engineering, Tottori University, 4-101 Koyama-cho Minami, Tottori 680-8552, Japan.ORCID 0000-0002-9292-8759
Tottori University · JP

Funding

Basis for Supporting Innovative Drug Discovery and Life Science Research JP21am0101070Japan Society for the Promotion of Science 19H04658Japan Society for the Promotion of Science 19H05780
6 · The paper itself

Abstract

Ladderane lipids (found in the membranes of anaerobic ammonium-oxidizing [anammox] bacteria) have unique ladder-like hydrophobic groups, and their highly strained exotic structure has attracted the attention of scientists. Although enzymes encoded in type II fatty acid biosynthesis (FASII) gene clusters in anammox bacteria, such as

Indexed as

MethionineS-AdenosylmethionineAcyl Carrier ProteinAnaerobic Ammonia OxidationBacteriaBacterial ProteinsLipidsMethyltransferasesRacemethionineAcyl Carrier ProteinBacterial ProteinsLipidsMethionineMethyltransferasesRacemethionineS-AdenosylmethionineAlphaFoldanammoxfatty acid biosynthesisladderane lipidmethyltransferase

Identifiers

PMID36614187
PMCPMC9821293
OpenAlexW4313427599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.